Eckert & Ziegler
Pharma manufacturing news in brief
May 1, 2012Manufacturing and Production Aptar Pharma, Ark Therapeutics, Cambrex, Eckert & Ziegler, Granules India and Omkar Speciality Chemicals
Cambrex facility passes FDA inspection, low-cost inhaler launched by Aptar, plus updates from Eckert & Ziegler, Granules India and Omkar …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
